Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 3.850
0.00 (0.00%)
Aug 6, 2026, 12:18 PM AEST
Vitrafy Life Sciences Market Cap
Vitrafy Life Sciences has a market cap or net worth of 293.37 million as of August 5, 2026. Its market cap has increased by 180.16% in one year.
Market Cap
293.37M
Enterprise Value
267.57M
Revenue
3.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.85
ChartMarket Cap Chart
Since November 26, 2024, Vitrafy Life Sciences's market cap has increased from 126.42M to 293.37M, an increase of 132.05%. That is a compound annual growth rate of 64.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 281.17M | 244.04% |
| Dec 30, 2025 | 81.73M | -24.71% |
| Dec 31, 2024 | 108.54M | -14.14% |
| Nov 26, 2024 | 126.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cuscal | 1.01B |
| Aura Consolidated Group | 679.14M |
| FINEOS Corporation Holdings | 648.31M |
| Tyro Payments | 445.04M |
| Acusensus | 169.24M |
| Wrkr Ltd | 142.60M |
| EML Payments | 124.37M |
| Decidr AI Industries | 119.48M |